Cargando…

ITGB3 promotes cisplatin resistance in osteosarcoma tumors

OBJECTIVE: Osteosarcoma is the most malignant and common primary bone tumor with a high rate of recurrence that mainly occurs in children and young adults. Therefore, it is vital to facilitate the development of novel effective therapeutic means and improve the overall prognosis of osteosarcoma pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qian, Chen, Guangyou, Jiang, Huachai, Dai, Haoping, Li, Dongdong, Zhu, Kai, Zhang, Kaiquan, Shen, Huarui, Xu, Houping, Li, Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134362/ https://www.ncbi.nlm.nih.gov/pubmed/36772869 http://dx.doi.org/10.1002/cam4.5585

Ejemplares similares

Identification of genes contributing to cisplatin resistance in osteosarcoma cells
por: Xie, Mingzhong, et al.
Publicado: (2022)

CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype
por: Li, Han, et al.
Publicado: (2022)

Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma
por: Liu, Yufeng, et al.
Publicado: (2020)

CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation
por: Lu, Shiqi, et al.
Publicado: (2023)

Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma
por: Wu, Zhihong, et al.
Publicado: (2011)

Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer
por: Lin, Feikai, et al.
Publicado: (2022)

ITGA5 and ITGB1 contribute to Sorafenib resistance by promoting vasculogenic mimicry formation in hepatocellular carcinoma
por: Shi, Ying, et al.
Publicado: (2022)

miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8
por: Cui, Yajie, et al.
Publicado: (2018)

Anoctamin 5 promotes osteosarcoma development by increasing degradation of Nel-like proteins 1 and 2
por: Pan, Runsang, et al.
Publicado: (2021)

LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis
por: Chen, Huiyong, et al.
Publicado: (2023)

GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma
por: Xie, Chaofan, et al.
Publicado: (2021)

Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor
por: Peng, Daohu, et al.
Publicado: (2021)

MiR-183 Regulates ITGB1P Expression and Promotes Invasion of Endometrial Stromal Cells
por: Chen, Jie, et al.
Publicado: (2015)

LncRNA ITGB2-AS1 Could Promote the Migration and Invasion of Breast Cancer Cells through Up-Regulating ITGB2
por: Liu, Mengyao, et al.
Publicado: (2018)

MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
por: Qiu, Chensheng, et al.
Publicado: (2020)

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
por: Zhou, Yong, et al.
Publicado: (2014)

The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair
por: Xu, Liang, et al.
Publicado: (2020)

Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail
por: Fang, Shuo, et al.
Publicado: (2016)

Hedgehog/GLI1 signaling pathway regulates the resistance to cisplatin in human osteosarcoma
por: Chen, Daosen, et al.
Publicado: (2021)

Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways
por: Cheng, Shengwen, et al.
Publicado: (2023)

Shear-Induced ITGB4 Promotes Endothelial Cell Inflammation and Atherosclerosis
por: Kong, Xiangquan, et al.
Publicado: (2022)

KCNF1 promotes lung cancer by modulating ITGB4 expression
por: Chen, Ching-Yi, et al.
Publicado: (2022)

Circular RNA expression pattern in cisplatin-resistant osteosarcoma cells
por: Han, Jianhua, et al.
Publicado: (2020)

Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells
por: Zhang, Zhengpei, et al.
Publicado: (2017)

Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
por: Li, Hong-Bo, et al.
Publicado: (2021)

LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Deng, Biyong, et al.
Publicado: (2021)

MicroRNA-1226-3p has a tumor-promoting role in osteosarcoma
por: Li, Yong, et al.
Publicado: (2021)

NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017)

The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma
por: Niu, Jianfang, et al.
Publicado: (2022)

A Pan-Cancer Analysis of the Oncogenic Role of Integrin Beta4 (ITGB4) in Human Tumors
por: Huang, Wenjie, et al.
Publicado: (2021)

Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells
por: Sun, Xilong, et al.
Publicado: (2017)

ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway
por: Wen, Xin, et al.
Publicado: (2022)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

ITGB4 is a novel prognostic factor in colon cancer
por: Li, Meng, et al.
Publicado: (2019)

Exosomal CTCF Confers Cisplatin Resistance in Osteosarcoma by Promoting Autophagy via the IGF2-AS/miR-579-3p/MSH6 Axis
por: Zhan, Haibo, et al.
Publicado: (2022)

Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages
por: Wang, Jincheng, et al.
Publicado: (2022)

MicroRNA-22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma
por: Meng, Chen-Yang, et al.
Publicado: (2020)

CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP‐9/PI3K/AKT pathway
por: Chen, Houping, et al.
Publicado: (2021)

Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer
por: Wu, Pancheng, et al.
Publicado: (2019)

Platelet-derived extracellular vesicles inhibit ferroptosis and promote distant metastasis of nasopharyngeal carcinoma by upregulating ITGB3
por: Li, Fei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k73io2gf6eaaf5je1a8gdc8iip